The board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.Powered by Capital Market - Live News

The board of Tarsons Products at its meeting held on 06 February 2026 has approved the appointment of Vinesh Mohan Kriplani (DIN: 08212644) as an Additional Director (Category: Non-Executive Independent Director). The board also accepted the resignation of Girish Paman Vanvari (DIN:07376482) as an Independent Director of the Company. Powered by Capital Market - Live News

Net profit of Tarsons Products declined 4.18% to Rs 5.04 crore in the quarter ended December 2025 as against Rs 5.26 crore during the previous quarter ended December 2024. Sales rose 12.76% to Rs 107.89 crore in the quarter ended December 2025 as against Rs 95.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales107.8995.68 13 OPM %29.2130.97 - PBDT33.8925.46 33 PBT8.868.05 10 NP5.045.26 -4 Powered by Capital Market - Live News

Tarsons Products will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News

Net profit of Tarsons Products declined 67.74% to Rs 3.32 crore in the quarter ended September 2025 as against Rs 10.29 crore during the previous quarter ended September 2024. Sales rose 3.10% to Rs 102.33 crore in the quarter ended September 2025 as against Rs 99.25 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales102.3399.25 3 OPM %26.8225.49 - PBDT28.0728.90 -3 PBT5.5914.87 -62 NP3.3210.29 -68 Powered by Capital Market - Live News